Hunan Fangsheng Pharm Co Ltd Cash Flow Conversion Efficiency
Hunan Fangsheng Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥95.63 Million ≈ $13.99 Million USD) by net assets (CN¥1.75 Billion ≈ $256.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hunan Fangsheng Pharm Co Ltd (2011–2025)
Cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025. This chart illustrates how Hunan Fangsheng Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hunan Fangsheng Pharm Co Ltd (603998) stock price for real-time trading data and today's change.
Hunan Fangsheng Pharm Co Ltd Cash Flow Conversion Ratio Explained
Hunan Fangsheng Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hunan Fangsheng Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their cash flow conversion efficiency. Also see 603998 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Burelle SA
PA:BUR
|
0.141x |
|
Ncs Testing Technology Co Ltd
SHE:300797
|
0.012x |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
-0.040x |
|
Shenzhen Jinjia Color Printing Group Co Ltd
SHE:002191
|
0.050x |
|
Obsidian Energy Ltd
TO:OBE
|
0.027x |
|
SHENWAN HONGYUAN GR.H YC1
F:2X2A
|
0.062x |
|
Shore Bancshares Inc
NASDAQ:SHBI
|
0.072x |
|
Cita Mineral Investindo Tbk PT
JK:CITA
|
0.043x |
Annual Cash Flow Conversion Efficiency for Hunan Fangsheng Pharm Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025. Review Hunan Fangsheng Pharm Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.80 Billion ≈ $263.81 Million |
CN¥384.63 Million ≈ $56.28 Million |
0.213x | +89.86% |
| 2024-12-31 | CN¥1.73 Billion ≈ $253.87 Million |
CN¥194.95 Million ≈ $28.53 Million |
0.112x | +103.94% |
| 2023-12-31 | CN¥1.59 Billion ≈ $232.48 Million |
CN¥87.54 Million ≈ $12.81 Million |
0.055x | -72.45% |
| 2022-12-31 | CN¥1.51 Billion ≈ $220.66 Million |
CN¥301.63 Million ≈ $44.14 Million |
0.200x | +40.48% |
| 2021-12-31 | CN¥1.30 Billion ≈ $190.76 Million |
CN¥185.63 Million ≈ $27.16 Million |
0.142x | -23.85% |
| 2020-12-31 | CN¥1.27 Billion ≈ $185.22 Million |
CN¥236.66 Million ≈ $34.63 Million |
0.187x | +38.29% |
| 2019-12-31 | CN¥1.20 Billion ≈ $175.95 Million |
CN¥162.58 Million ≈ $23.79 Million |
0.135x | -14.54% |
| 2018-12-31 | CN¥1.11 Billion ≈ $162.84 Million |
CN¥176.06 Million ≈ $25.76 Million |
0.158x | +925.77% |
| 2017-12-31 | CN¥1.04 Billion ≈ $151.83 Million |
CN¥16.00 Million ≈ $2.34 Million |
0.015x | -87.27% |
| 2016-12-31 | CN¥979.69 Million ≈ $143.36 Million |
CN¥118.70 Million ≈ $17.37 Million |
0.121x | +24.64% |
| 2015-12-31 | CN¥931.73 Million ≈ $136.34 Million |
CN¥90.57 Million ≈ $13.25 Million |
0.097x | -13.08% |
| 2014-12-31 | CN¥841.94 Million ≈ $123.20 Million |
CN¥94.16 Million ≈ $13.78 Million |
0.112x | -64.82% |
| 2013-12-31 | CN¥386.85 Million ≈ $56.61 Million |
CN¥122.97 Million ≈ $17.99 Million |
0.318x | +318.63% |
| 2012-12-31 | CN¥318.83 Million ≈ $46.66 Million |
CN¥24.21 Million ≈ $3.54 Million |
0.076x | -69.88% |
| 2011-12-31 | CN¥258.49 Million ≈ $37.83 Million |
CN¥65.16 Million ≈ $9.54 Million |
0.252x | -- |
About Hunan Fangsheng Pharm Co Ltd
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological … Read more